BridgeMD
New treatment option for Prostate Cancer (Diagnosis)
Official title Prehabilitation to Patients With Prostate Cancer
ClinicalTrials.gov ID: NCT07162987
What this study is testing
- What it's testing
- The goal of this feasibility study is to test a newly developed, multicomponent prehabilitation intervention to patients with prostate cancer, to improve their resilience to treatment side-effects. The main questions it aims to answer are: Are patients and their close relatives willing to take part in prehabilitation?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Diagnosed with prostate cancer
- min 18 years old
- Treatment: Androgen deprivation therapy and raditation therapy
- Resident in Vejle Municipality or Esbjerg Municipality
- Can take part in residential prehabiliation in week 43 or 50, 2025, as well as physical exsercise training in the municipality
You likely can't join if
- Persons who do not fulfil the inclusion criteria will be excluded
See the full eligibility criteria
- Diagnosed with prostate cancer
- min 18 years old
- Treatment: Androgen deprivation therapy and raditation therapy
- Resident in Vejle Municipality or Esbjerg Municipality
- Can take part in residential prehabiliation in week 43 or 50, 2025, as well as physical exsercise training in the municipality
- Willing to take part in a research study
- Suited to take part in group sessions
- Be able to read and be understood in Danish
- Be responsible for own personal hygiene and medications at the 4-day residential stay
- Persons who do not fulfil the inclusion criteria will be excluded
The study team makes the final eligibility decision.
Where it's taking place
- Esbjerg, Region Syddanmark, Denmark
- Nyborg, Region Syddanmark, Denmark
- Vejle, Region Syddanmark, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Esbjerg, Region Syddanmark, Denmark; Nyborg, Region Syddanmark, Denmark; Vejle, Region Syddanmark, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.